The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Hepatic Encephalopathy and Liver Transplant: The Past, Present, and Future Towards Equitable Access
Liver Transpl. 2021 May 21. doi: 10.1002/lt.26099. Online ahead of print.
Chathur Acharya1, Jasmohan S Bajaj1
Author information
1Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.
Abstract
Cirrhosis is a debilitating chronic disease with high morbidity and mortality, with the only real cure being liver transplantation. Currently, we allocate organs for transplantation based on the model for end-stage liver disease sodium (MELD-Na) score that does not account for hepatic encephalopathy (HE). HE affects patients, families, and the healthcare system because of high rates of recurrence and major readmission burden. Moreover, HE casts a long shadow even after liver transplant (LT). Accounting for HE and incorporating it into the current allocation system has many proponents, but the framework to do this is currently lacking because of differences in consensus or in operationalization parameters. We review the latest evidence of the burden of HE, management of HE pre- and post-LT, and evaluate pros and cons of several methods of diagnosing HE objectively to ensure early and equitable access to LT in this underserved population.